Macrocyclic compounds useful as pharmaceuticals
US8329742B2 · kind B2 · utility
9Cited by
6References
32Claims
0Family size
Assignee
Inventors
- Roch Boivin
- Kenichi Chiba
- Jesse Chow
- Hong Du
- Yoshihito Eguchi
- Masanori Fujita
- Masaki Goto
- Fabian Gusovsky
- Jean-Christophe Harmange
- Atsushi Inoue
- Yimin Jiang
- Megumi Kawada
- Takatoshi Kawai
- Yoshiyuki Kawakami
- Akifumi Kimura
- Makoto Kotake
- Yoshikazu Kuboi
- Charles Lemelin
- Xiang Li
- Tomohiro Matsushima
- Yoshiharu Mizui
- Kenzo Muramoto
- Hideki Sakurai
- Yong-Chun Shen
- Hiroshi Shirota
- Mark Spyvee
- Isao Tanaka
- John Wang
- Satoshi Yamamoto
- Naoki Yoneda
Key dates
| Filing date | Jul 20, 2010 |
| Grant date | Dec 11, 2012 |
| Priority date | — |
| Expiry date | Jul 20, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods for the use of compounds having formula (I) in the treatment of various disorders including inflammatory or autoimmune disorders, and disorders involving malignancy or increased angiogenesis, wherein R1-R11, t, X, Y, Z, and n are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.